Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
LONDON, April 05, 2022 (GLOBE NEWSWIRE) -- Her Roomies “the Company” founded in Spain, is making moves to increase its market share in the UK. Already listing student residences in the UK, the...
-
CERRITOS, Calif., April 04, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute of Hope and Innovation (NASDAQ: TOI) today announced the appointment of Mihir Shah as chief financial officer, effective...
-
LAS VEGAS, March 30, 2022 (GLOBE NEWSWIRE) -- Marathon Digital Holdings, Inc. (NASDAQ:MARA) ("Marathon" or "Company"), one of the largest enterprise Bitcoin self-mining companies in North America,...
-
Dublin, March 28, 2022 (GLOBE NEWSWIRE) -- The "Carboxymethyl cellulose Market by Purity Level, Application and Property: Global Opportunity Analysis and Industry Forecast, 2021-2030" report has...
-
Dublin, March 25, 2022 (GLOBE NEWSWIRE) -- The "Global Carboxymethyl Cellulose Market By Purity Level, By Application, By Property, By Regional Outlook, Industry Analysis Report and Forecast,...
-
New team focused on expanding its GPCR-focused structure-based drug design platform and enhancing translational medicine capabilities‘Venture-like’ capital allocation approach to focus pipeline...
-
Dublin, March 22, 2022 (GLOBE NEWSWIRE) -- The "Operational Risk Management Solution Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Deployment and Enterprise Size" report has been...
-
Dublin, March 22, 2022 (GLOBE NEWSWIRE) -- The "Field Activity Management Market by Component (Solution and Services (Consulting, Integration, and training and support)), Deployment Mode,...
-
TORONTO, March 21, 2022 (GLOBE NEWSWIRE) -- The 2nd National Summit on Episodic Disabilities and Employment, hosted by Realize, will open (via Zoom) on March 23rd with a special pre-Summit spotlight...
-
SAN DIEGO, March 21, 2022 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of...